180 related articles for article (PubMed ID: 15237099)
1. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS blocks CGRP and adrenomedullin vasoactive responses in the microvasculature.
Grant AD; Tam CW; Lazar Z; Shih MK; Brain SD
Br J Pharmacol; 2004 Aug; 142(7):1091-8. PubMed ID: 15237099
[TBL] [Abstract][Full Text] [Related]
2. The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: a study using in vivo and in vitro assays in the mouse.
Tam C; Brain SD
J Mol Neurosci; 2004; 22(1-2):117-24. PubMed ID: 14742916
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
4. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.
Arulmani U; Schuijt MP; Heiligers JP; Willems EW; Villalón CM; Saxena PR
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):291-7. PubMed ID: 15228501
[TBL] [Abstract][Full Text] [Related]
5. The involvement of CGRP, adrenomedullin, and sensory nerves in remote vasomotor responses within the hamster cheek pouch microcirculation.
Miriel VA; Chen Y; Rivers RJ
Microvasc Res; 2009 Mar; 77(2):192-7. PubMed ID: 19084542
[TBL] [Abstract][Full Text] [Related]
6. Rat mesenteric small artery neurogenic dilatation is predominantly mediated by β
Søndergaard AM; Overgaard CB; Mazur A; Postnov DD; Matchkov VV; Aalkjaer C
J Physiol; 2019 Apr; 597(7):1819-1831. PubMed ID: 30693527
[TBL] [Abstract][Full Text] [Related]
7. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.
Edvinsson L; Alm R; Shaw D; Rutledge RZ; Koblan KS; Longmore J; Kane SA
Eur J Pharmacol; 2002 Jan; 434(1-2):49-53. PubMed ID: 11755165
[TBL] [Abstract][Full Text] [Related]
8. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
Hay DL; Christopoulos G; Christopoulos A; Sexton PM
Mol Pharmacol; 2006 Dec; 70(6):1984-91. PubMed ID: 16959943
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells.
Hay DL; Howitt SG; Conner AC; Doods H; Schindler M; Poyner DR
Br J Pharmacol; 2002 Sep; 137(1):80-6. PubMed ID: 12183333
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
Edvinsson L; Nilsson E; Jansen-Olesen I
Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
[TBL] [Abstract][Full Text] [Related]
11. Vascular actions of calcitonin gene-related peptide and adrenomedullin.
Brain SD; Grant AD
Physiol Rev; 2004 Jul; 84(3):903-34. PubMed ID: 15269340
[TBL] [Abstract][Full Text] [Related]
12. Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries.
Sheykhzade M; Lind H; Edvinsson L
Br J Pharmacol; 2004 Dec; 143(8):1066-73. PubMed ID: 15477223
[TBL] [Abstract][Full Text] [Related]
13. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.
Schindler M; Doods HN
Eur J Pharmacol; 2002 May; 442(3):187-93. PubMed ID: 12065071
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin inhibits neurotransmission of calcitonin gene-related peptide (CGRP)-containing vasodilator nerves in rat mesenteric resistance arteries.
Akiyama S; Kawasaki H; Shimogai A; Kurosaki Y
Peptides; 2001 Nov; 22(11):1887-93. PubMed ID: 11754977
[TBL] [Abstract][Full Text] [Related]
15. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow.
Tröltzsch M; Denekas T; Messlinger K
Eur J Pharmacol; 2007 May; 562(1-2):103-10. PubMed ID: 17349622
[TBL] [Abstract][Full Text] [Related]
16. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig.
Kapoor K; Arulmani U; Heiligers JP; Willems EW; Doods H; Villalón CM; Saxena PR
Eur J Pharmacol; 2003 Aug; 475(1-3):69-77. PubMed ID: 12954361
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat.
Petersen KA; Birk S; Doods H; Edvinsson L; Olesen J
Br J Pharmacol; 2004 Nov; 143(6):697-704. PubMed ID: 15504760
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor.
Wu D; Eberlein W; Rudolf K; Engel W; Hallermayer G; Doods H
Eur J Pharmacol; 2000 Jul; 400(2-3):313-9. PubMed ID: 10988349
[TBL] [Abstract][Full Text] [Related]
19. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture.
Takhshid MA; Poyner DR; Chabot JG; Fournier A; Ma W; Zheng WH; Owji AA; Quirion R
Br J Pharmacol; 2006 Jun; 148(4):459-68. PubMed ID: 16702994
[TBL] [Abstract][Full Text] [Related]
20. Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity.
Wu D; Doods H; Arndt K; Schindler M
Biochem Soc Trans; 2002 Aug; 30(4):468-73. PubMed ID: 12196117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
